At a glance
ClinicalIndex Comparison RecordN/ANot Yet Recruiting· 20 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Emicizumab Treatment on the Musculoskeletal System in Children With Hemophilia A: A Prospective Study
In Brief
An observational study for Hemophilia A and 2 related conditions. Not yet recruiting, targeting 20 participants across 1 site.
Detailed Summary
The aim of our study is to investigate the effects of emicizumab treatment on the musculoskeletal system in children with hemophilia A.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ANot Yet RecruitingOverdue
2026
First PostedSep 2025
Enrollment StartSep 2025
Primary CompletionNov 2025
Study CompletionFeb 2026
TodayJul 2026
First PostedSep 24, 2025
Enrollment StartSep 30, 2025
Primary CompletionNov 10, 2025
Study CompletionFeb 10, 2026
TodayJul 1, 2026
Enrollment to primary: 1 monthPosted 9 months ago